Skip to main content

Reporter Sept 9 2022

Cancer registries and sarcoma research

Sep. 13, 2022—The number of sarcoma research studies that use the two largest U.S. cancer registries is increasing, but over one-third of studies that asked the same research question reported conflicting findings.

Read more


Enhancing innate immunity in the lung

Sep. 12, 2022—Vanderbilt researchers show that a TLR4 agonist improves lung immune response and survival in a mouse model of bacterial pneumonia, supporting the development of this drug to protect against pneumonia in hospitalized patients.

Read more


PheWAS reveals post-COVID-19 diagnoses

Sep. 8, 2022—Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.

Read more


Simple Beginnings

Sep. 8, 2022—Vanderbilt held its annual Simple Beginnings ceremony for new doctoral students last week in Light Hall.

Read more


Diabetes research grant receives NIDDK renewal

Sep. 8, 2022—The Vanderbilt Diabetes Research and Training Center is celebrating its 49th year of continual operation with the five-year competitive renewal of a $10.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health.

Read more


Directorships honor VUMC leaders and philanthropic partners

Sep. 8, 2022—by Doug Campbell Last week, Vanderbilt University Medical Center held a Directorship Celebration to honor 21 leaders from across the enterprise in clinical care, research, education and administration. “Endowed directorships support the excellence of our leading physicians and scientists,” said Jeff Balser, MD, PhD, CEO of VUMC and Dean of Vanderbilt University School of Medicine....

Read more


Calkins lands national award for research on blinding eye diseases

Sep. 8, 2022—Vanderbilt's David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.

Read more


Family’s gift supports efforts of three pediatric clinicians

Sep. 8, 2022—The family of the late William (Bill) Long, MD, made a gift to establish the Dr. William R. Long Fund to support directorships, resident education, fellowships and psychologists in the Department of Pediatrics at Vanderbilt University Medical Center.

Read more


Immune cells drive beta cell loss in Type 2 diabetes

Sep. 8, 2022—Vanderbilt researchers have discovered details of pancreatic beta cell loss — and potential therapeutic targets — during conditions of overnutrition, as occurs in obesity.

Read more


Study tests drug to illuminate cancer during surgery

Sep. 8, 2022—A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.

Read more


Patient capacity command center created

Sep. 8, 2022—Vanderbilt has created a command center charged with identifying and eliminating capacity constraints throughout the health system that could limit the ability to consistently serve all patients in a timely and equitable manner.

Read more


Transplant docuseries lauded by Donate Life Hollywood

Sep. 8, 2022—“Last Chance Transplant,” the docuseries filmed at Vanderbilt in conjunction with 44 Blue Productions and Rock’n Robins Productions, received the 2022 Inspire Award on Thursday, Aug. 25, from Donate Life Hollywood.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more